How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Pharma and Healthcare · Forecast 2027–2033
Remote Patient Monitoring Systems Market
- By Product Type: Wearable Devices, Implantable Devices, Stationary Devices, Mobile Health Applications, Remote Monitoring Software
- By Application: Cardiac Monitoring, Diabetes Management, Respiratory Monitoring, Hypertension Management, Chronic Disease Management, Postoperative Care
- By End User: Hospitals, Home Healthcare, Ambulatory Care Centers, Clinics, Long-term Care Facilities
- By Connectivity Technology: Bluetooth, Wi-Fi, Cellular (3G/4G/5G), ZigBee, Satellite Communication
- By Data Management: Cloud-based Platforms, On-premise Solutions, Hybrid Systems
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Projected to reach $X,XXX.XM by 2033 on sustained demand. Market Outlook →
- 03 Growth - X.XX% CAGR across 2027–2033, with the full year-by-year model inside. Market Outlook →
- 04 Leading segment - Wearable Devices leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 305 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.184 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.192 →
Full report · locked preview
Everything inside the Remote Patient Monitoring Systems Market report
A complete, evidence-based study - 12 chapters and 128 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Application 6
End User 5
Connectivity Technology 5
Data Management 3
Companies profiled
Philips Healthcare
Medtronic
GE Healthcare
Honeywell Life Care Solutions
ResMed
Abbott Laboratories
Boston Scientific Corporation
BioTelemetry
Inc. (now part of Philips)
iRhythm Technologies
Nokia (Health division)
Withings
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Medtronic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →GE Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Honeywell Life Care Solutions
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →ResMed
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Abbott Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Boston Scientific Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →BioTelemetry
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Inc. (now part of Philips)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →iRhythm Technologies
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Nokia (Health division)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Withings
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Omron Healthcare
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →AliveCor
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Dexcom
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Masimo Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →
Global · 2025–2033
$9,756M by 2033 · 9.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Wearable Devices37.6
- Implantable Devices10.0
- Stationary Devices9.2
- Mobile Health Applications22.0
- Remote Monitoring Software21.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,551M → $3,339M · 10.1%
Europe$1,081M → $2,022M · 8.1%
Asia Pacific$987.1M → $2,220M · 10.7%
Latin America$611.1M → $1,406M · 11.0%
Middle East and Africa$470.1M → $1,080M · 11.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.512026
9.522027
9.542028
9.542029
9.552030
9.582031
9.592032
9.592033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Philips Healthcare21.4
- Medtronic20.2
- GE Healthcare7.0
- Honeywell Life Care Solutions5.2
- ResMed9.3
- Abbott Laboratories8.8
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type23.4%
Application19.1%
End User18.5%
Connectivity Technology15.4%
Data Management23.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.2
- Europe20.1
- Asia Pacific22.1
- Latin America14.0
- Middle East and Africa10.7
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Philips Healthcare | 88 | 84 | 76 | 81 | 79 | 75 | 81 |
| Medtronic | 78 | 70 | 93 | 68 | 78 | 80 | 78 |
| GE Healthcare | 78 | 75 | 71 | 69 | 70 | 82 | 74 |
| Honeywell Life Care Solutions | 69 | 73 | 58 | 76 | 77 | 57 | 68 |
| ResMed | 57 | 63 | 57 | 59 | 77 | 58 | 62 |
| Abbott Laboratories | 59 | 62 | 55 | 67 | 59 | 56 | 60 |
| Boston Scientific Corporation | 46 | 42 | 41 | 54 | 43 | 61 | 48 |
| BioTelemetry | 46 | 48 | 43 | 41 | 42 | 39 | 43 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Philips Healthcare
- Medtronic
- GE Healthcare
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Philips Healthcare | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Medtronic | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| GE Healthcare | ◐ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Honeywell Life Care Solutions | ✓ | ◐ | − | ◐ | ◐ | − |
| ResMed | − | ◐ | ◐ | − | ✓ | − |
| Abbott Laboratories | ◐ | ◐ | − | ◐ | − | ◐ |
| Boston Scientific Corporation | − | − | − | − | ◐ | − |
| BioTelemetry | − | − | − | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Philips Healthcare81
2Medtronic78
3GE Healthcare74
4Honeywell Life Care Solutions68
5ResMed62
6Abbott Laboratories60
7Boston Scientific Corporation48
8BioTelemetry43
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Philips HealthcareMedtronic
Challenger2
Strong scale, closing on the leaders.
GE HealthcareHoneywell Life Care Solutions
Contender2
Focused players with pockets of strength.
ResMedAbbott Laboratories
Niche2
Specialists in a single segment or region.
Boston Scientific CorporationBioTelemetry
Go-to-market strategy
Land Product Type in North America, then scale across Remote Patient Monitoring Systems Market — a $480M beachhead inside a $8.33B market.
Beachhead (SOM)$480Mobtainable near-term
Serviceable (SAM)$3.12Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Wearable Devices
Best fit — highest urgency & budget in Product Type.
Economic buyer75 fit
Implantable Devices
Strong fit — clear ROI and a fast path to value.
End user65 fit
Stationary Devices
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel27%
Digital / self-serve19%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Remote Patient Monitoring Systems Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified22%
Evaluation13%
Closed-won7%
$11.6KCAC
$54KLTV
4.7:1LTV : CAC
< 2 moCAC payback
Investment thesis
Remote Patient Monitoring Systems Market is a resilient opportunity — $1.78B by 2033, compounding at 4.9%.
TAM · 2025$1.22Btoday
TAM · 2033$1.78Bforecast
CAGR4.9%2027–2033
Cumulative$13.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.78BTotal addressable market
SAM$703MServiceable available market
SOM$124MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.9% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.78BLarge & growingTAM by 2033 at 4.9% CAGR
$703MServiceable nowreachable with today’s model
$124MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.39BBear3.2% CAGR
$1.78BBase4.9% CAGR
$2.28BBull6.5% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Remote Patient Monitoring Systems Market — a $6.47B market by 2033. Plan: grow share from 11.3% to 17.8%.
Market size · 2033$6.47Btotal addressable
Market CAGR9.2%2027–2033
Target share17.8%from 11.3% today
Revenue ambition$1.15Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.3% | 17.8% | At risk |
| Revenue | $708M | $1.15B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 28.1% | 38.3% | On track |
| Customer retention | 91.2% | 92.1% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $119M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeAt risk
- Execution & talentOn track
Sales deck · value proposition
Win the Remote Patient Monitoring Systems Market conversation — a $8.23B market you can size, segment and defend in minutes.
Market size · 2033$8.23Btotal opportunity
Growth5.9%CAGR to 2033
Addressable buyers1,483+accounts in scope
Typical ROI4.6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.6×return on cost, year one
< 3 mopayback period
$72K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Philips HealthcareMedtronicGE HealthcareHoneywell Life Care SolutionsResMedAbbott LaboratoriesBoston Scientific CorporationBioTelemetry+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Remote Patient Monitoring Systems Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Remote Patient Monitoring Systems Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Pharma and Healthcare · scroll →Advanced Prosthetics and Exoskeletons Market
Market size, share, segmentation and regional forecast.
$3.9B by 2032 · 5.98% CAGR
View reportAdvanced Animal Ventilators Market
Market size, share, segmentation and regional forecast.
$7.1B by 2031 · 6.06% CAGR
View reportClinical Decision Support System (CDSS) Market
Market size, share, segmentation and regional forecast.
$9.5B by 2033 · 4.04% CAGR
View reportAdjunctive Haemostats Market
Market size, share, segmentation and regional forecast.
$10.8B by 2032 · 8.01% CAGR
View reportAdditives for Inkjet Inks Market
Market size, share, segmentation and regional forecast.
$10.4B by 2032 · 4.30% CAGR
View reportAcyclovir for Injection Market
Market size, share, segmentation and regional forecast.
$13.2B by 2033 · 3.35% CAGR
View reportActivated Carbon for Food & Beverages Market
Market size, share, segmentation and regional forecast.
$2.3B by 2031 · 8.53% CAGR
View reportAconitine Market
Market size, share, segmentation and regional forecast.
$13.1B by 2031 · 6.91% CAGR
View reportPractice Management System Market
Market size, share, segmentation and regional forecast.
$7.9B by 2031 · 7.84% CAGR
View reportAcetoacet-o-Toludide Market
Market size, share, segmentation and regional forecast.
$9.4B by 2032 · 8.24% CAGR
View reportAceglutamide for Injection Market
Market size, share, segmentation and regional forecast.
$14.6B by 2031 · 5.59% CAGR
View reportTemperature Controlled Packaging Solutions for Pharmaceuticals Market
Market size, share, segmentation and regional forecast.
$14.4B by 2032 · 8.66% CAGR
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.